Sen. Susan Collins disclosed she has a benign essential tremor, a neurological condition causing involuntary shaking. The announcement comes as the Maine Republican faces a difficult reelection campaign, with early polling showing a tight race against her Democratic challenger, who has already raised $5.2 million in the first quarter. Collins, 73, has served in the Senate for 28 years and holds a leadership role on the Appropriations Committee.
The disclosure immediately impacts the political calculus for her campaign and opposing groups. Political strategists on both sides will assess how voters perceive a health issue, even a non-life-threatening one, in a high-stakes election. Opponents will scrutinize her public appearances more closely for any visible signs, seeking to leverage it as a sign of vulnerability and questioning her long-term capacity to serve.
This development directly affects the money flowing into the Maine Senate race, projected to exceed $100 million in total spending. Corporate PACs and major industry donors, who rely on Collins' influence as vice chair of the powerful Senate Appropriations Committee, must now weigh the added risk to her reelection prospects. Her campaign raised $7.8 million in the first quarter, and continued fundraising strength is essential to counter anticipated spending from national Democratic organizations like the Senate Majority PAC.
Collins' long tenure and moderate stance have made her a key player in bipartisan legislative efforts, particularly on defense and healthcare funding through her committee assignments. Her position on the Appropriations Committee directly influences billions in federal contracts and research grants, impacting companies like General Dynamics and Pfizer, both past donors. A weakened position or potential loss would shift the balance of power on Appropriations, affecting federal spending priorities for these and other major players.
The revelation also presents a challenge for her campaign's messaging, requiring careful management to prevent the benign tremor from becoming a central campaign issue. Health disclosures have forced candidates to increase transparency while battling narratives from opponents. The Collins campaign must now manage this additional layer of public perception, alongside traditional attacks on her legislative record.
Her reelection is a top priority for Senate Republican leadership, who see her seat as vital for maintaining their narrow majority. Losing Collins would mean losing not only a seasoned legislator but also a vote on key financial and economic legislation, including future budget appropriations and potential tax reforms. The National Republican Senatorial Committee is expected to increase its financial commitment to her race significantly.
